The consensus guidelines of the Geriatric Society of Chinese Medical Association on the
management of atrial fibrillation (AF) in the elderly was first published in 2011 and updated …

One in six ischaemic stroke patients has an embolic stroke of undetermined source (ESUS),
defined as a stroke with unclear aetiology despite recommended diagnostic evaluation. The …

Aims Recent trial data demonstrate beneficial effects of active rhythm management in
patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is …

Atrial fibrillation is one of the most common cardiac arrhythmias and is a major cause of
ischaemic stroke. Recent findings indicate the importance of atrial fibrillation burden (device …

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is not a dichotomous
disease trait. Technological innovations enable long-term rhythm monitoring in many …

Abstract Background ARTESiA (Apixaban for the Reduction of Thrombo-Embolism in
Patients With Device-Detected Sub-Clinical Atrial Fibrillation) demonstrated that apixaban …

Atrial fibrillation (AF) is a complex disease requiring a multidomain and (usually) long-term
management, thus posing a significant burden to patients with AF, practitioners, and health …

Automated continuous rhythm monitoring has been made possible with the extensive use of
cardiac implantable electronic devices (CIEDs). A highly prevalent finding in devices with …

Background Atrial fibrillation (AF) often remains undiagnosed, and it independently raises
the risk of ischemic stroke, which is largely reversible by oral anticoagulation. Although …

Atrial fibrillation (AF) may be asymptomatic and the extensive monitoring capabilities of
cardiac implantable electronic devices (CIEDs) revealed asymptomatic atrial tachi …